Changes in Lymphoid Cell Distribution After Intraperitoneal Administration of 32p Colloids

Authors

  • M. Onsrud Departments of Gynecologic Oncology and Hematology, the Norwegian Radium Hospital, Oslo, Norway; Institute of Transplantation Imsmunology, the National Hospital and University of Oslo, Oslo, Norway
  • V. Bosnes Departments of Gynecologic Oncology and Hematology, the Norwegian Radium Hospital, Oslo, Norway; Institute of Transplantation Imsmunology, the National Hospital and University of Oslo, Oslo, Norway
  • I. Grahm Departments of Gynecologic Oncology and Hematology, the Norwegian Radium Hospital, Oslo, Norway; Institute of Transplantation Imsmunology, the National Hospital and University of Oslo, Oslo, Norway
  • A. Engeset Departments of Gynecologic Oncology and Hematology, the Norwegian Radium Hospital, Oslo, Norway; Institute of Transplantation Imsmunology, the National Hospital and University of Oslo, Oslo, Norway

DOI:

https://doi.org/10.3109/02841868509136061

Abstract

The effect of intraperitoneal administration of 32P colloids on the distribution of T lymphocyte subpopulations and monocytes was studied using monoclonal antibodies and a flow cytometry technique. Thirty-nine patients with ovarian carcinoma without residual tumor after primary operation were examined either before the administration of 260 to 370 MBq of 32P, 4 to 6 days after therapy, or 4 to 10 months after therapy. A significant reduction of circulating OKT4+ (T helper) cells occurred after therapy, and the reduction lasted throughout the observation period. Monocyte numbers were not significantly changed. It is concluded that intraperitoneal instillation of the 32P isotope may induce the same type of changes in circulating lymphoid cells as those seen after external field irradiation.

Downloads

Download data is not yet available.

Downloads

Published

1985-01-01

How to Cite

Onsrud, M., Bosnes, V., Grahm, I., & Engeset, A. (1985). Changes in Lymphoid Cell Distribution After Intraperitoneal Administration of 32p Colloids. Acta Oncologica, 24(4), 331–335. https://doi.org/10.3109/02841868509136061